Los Angeles, CA -- (SBWIRE) -- 02/14/2020 -- The Major Key Players Focus in this Report are: Bluebird Bio, Sangamo, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical Inc., Advantagene

The report offers highly detailed competitive analysis of the Global Gene Therapy industry, where the business and industry growth of leading companies are thoroughly evaluated on the basis of production, product portfolio, recent developments, technology, geographical footprint, and various other factors. The authors of the report have also provided information on future changes in the competitive landscape and the expected nature of competition in the global Gene Therapy industry. This will help players to prepare themselves well for any unforeseen situations in the industry competition and give a tough competition to other players in the global Gene Therapy industry.

Click here! For Updated Sample Copy of this Report@ https://www.qyresearch.com/sample-form/form/1436547/global-gene-therapy-market

As part of geographic analysis of the global Gene Therapy market, the report digs deep into the growth of key regions and countries, including but not limited to North America, the US, Europe, the UK, Germany, France, Asia Pacific, China, and the MEA. All of the geographies are comprehensively studied on the basis of share, consumption, production, future growth potential, CAGR, and many other parameters.

Top Key Players Covered:

Bluebird Bio, Sangamo, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical Inc., Advantagene

Market Segments By Type Covered:

Ex vivo, In Vivo

Market Segments By Application Covered:

Cancer, Monogenic, Infectious disease, Cardiovascular disease, Other

Get Customized Report in your Inbox within 24 hours @ https://www.qyresearch.com/customize-request/form/1436547/global-gene-therapy-market

Regions Covered in the Global Gene Therapy Market:

- The Middle East and Africa (GCC Countries and Egypt)
- North America (the United States, Mexico, and Canada)
- South America (Brazil etc.)
- Europe (Turkey, Germany, Russia UK, Italy, France, etc.)
- Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Highlights of the Report
- Accurate market size and CAGR forecasts for the period 2020-2025
- Identification and in-depth assessment of growth opportunities in key segments and regions
- Detailed company profiling of top players of the global Gene Therapy market
- Exhaustive research on innovation and other trends of the global Gene Therapy market
- Reliable industry value chain and supply chain analysis
- Comprehensive analysis of important growth drivers, restraints, challenges, and growth prospects

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gene Therapy Revenue
1.4 Market Analysis by Type
1.4.1 Global Gene Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Ex vivo
1.4.3 In Vivo
1.5 Market by Application
1.5.1 Global Gene Therapy Market Share by Application: 2020 VS 2026
1.5.2 Cancer
1.5.3 Monogenic
1.5.4 Infectious disease
1.5.5 Cardiovascular disease
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends by Regions
2.1 Gene Therapy Market Perspective (2015-2026)
2.2 Gene Therapy Growth Trends by Regions
2.2.1 Gene Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Gene Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Gene Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Gene Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Gene Therapy Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy Players by Market Size
3.1.1 Global Top Gene Therapy Players by Revenue (2015-2020)
3.1.2 Global Gene Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Gene Therapy Market Concentration Ratio
3.2.1 Global Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Gene Therapy Revenue in 2019
3.3 Gene Therapy Key Players Head office and Area Served
3.4 Key Players Gene Therapy Product Solution and Service
3.5 Date of Enter into Gene Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Gene Therapy Historic Market Size by Type (2015-2020)
4.2 Global Gene Therapy Forecasted Market Size by Type (2021-2026)

5 Gene Therapy Breakdown Data by Application (2015-2026)
5.1 Global Gene Therapy Market Size by Application (2015-2020)
5.2 Global Gene Therapy Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Gene Therapy Market Size (2015-2020)
6.2 Gene Therapy Key Players in North America (2019-2020)
6.3 North America Gene Therapy Market Size by Type (2015-2020)
6.4 North America Gene Therapy Market Size by Application (2015-2020)

7 Europe
7.1 Europe Gene Therapy Market Size (2015-2020)
7.2 Gene Therapy Key Players in Europe (2019-2020)
7.3 Europe Gene Therapy Market Size by Type (2015-2020)
7.4 Europe Gene Therapy Market Size by Application (2015-2020)

8 China
8.1 China Gene Therapy Market Size (2015-2020)
8.2 Gene Therapy Key Players in China (2019-2020)
8.3 China Gene Therapy Market Size by Type (2015-2020)
8.4 China Gene Therapy Market Size by Application (2015-2020)

9 Japan
9.1 Japan Gene Therapy Market Size (2015-2020)
9.2 Gene Therapy Key Players in Japan (2019-2020)
9.3 Japan Gene Therapy Market Size by Type (2015-2020)
9.4 Japan Gene Therapy Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Gene Therapy Market Size (2015-2020)
10.2 Gene Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gene Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Gene Therapy Market Size by Application (2015-2020)

11 India
11.1 India Gene Therapy Market Size (2015-2020)
11.2 Gene Therapy Key Players in India (2019-2020)
11.3 India Gene Therapy Market Size by Type (2015-2020)
11.4 India Gene Therapy Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Gene Therapy Market Size (2015-2020)
12.2 Gene Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Gene Therapy Market Size by Type (2015-2020)
12.4 Central & South America Gene Therapy Market Size by Application (2015-2020)

13Key Players Profiles
13.1 Bluebird Bio
13.1.1 Bluebird Bio Company Details
13.1.2 Bluebird Bio Business Overview and Its Total Revenue
13.1.3 Bluebird Bio Gene Therapy Introduction
13.1.4 Bluebird Bio Revenue in Gene Therapy Business (2015-2020))
13.1.5 Bluebird Bio Recent Development
13.2 Sangamo
13.2.1 Sangamo Company Details
13.2.2 Sangamo Business Overview and Its Total Revenue
13.2.3 Sangamo Gene Therapy Introduction
13.2.4 Sangamo Revenue in Gene Therapy Business (2015-2020)
13.2.5 Sangamo Recent Development
13.3 Spark Therapeutics
13.3.1 Spark Therapeutics Company Details
13.3.2 Spark Therapeutics Business Overview and Its Total Revenue
13.3.3 Spark Therapeutics Gene Therapy Introduction
13.3.4 Spark Therapeutics Revenue in Gene Therapy Business (2015-2020)
13.3.5 Spark Therapeutics Recent Development
13.4 Dimension Therapeutics
13.4.1 Dimension Therapeutics Company Details
13.4.2 Dimension Therapeutics Business Overview and Its Total Revenue
13.4.3 Dimension Therapeutics Gene Therapy Introduction
13.4.4 Dimension Therapeutics Revenue in Gene Therapy Business (2015-2020)
13.4.5 Dimension Therapeutics Recent Development
13.5 Avalanche Bio
13.5.1 Avalanche Bio Company Details
13.5.2 Avalanche Bio Business Overview and Its Total Revenue
13.5.3 Avalanche Bio Gene Therapy Introduction
13.5.4 Avalanche Bio Revenue in Gene Therapy Business (2015-2020)
13.5.5 Avalanche Bio Recent Development
13.6 Celladon
13.6.1 Celladon Company Details
13.6.2 Celladon Business Overview and Its Total Revenue
13.6.3 Celladon Gene Therapy Introduction
13.6.4 Celladon Revenue in Gene Therapy Business (2015-2020)
13.6.5 Celladon Recent Development
13.7 Vical Inc.
13.7.1 Vical Inc. Company Details
13.7.2 Vical Inc. Business Overview and Its Total Revenue
13.7.3 Vical Inc. Gene Therapy Introduction
13.7.4 Vical Inc. Revenue in Gene Therapy Business (2015-2020)
13.7.5 Vical Inc. Recent Development
13.8 Advantagene
13.8.1 Advantagene Company Details
13.8.2 Advantagene Business Overview and Its Total Revenue
13.8.3 Advantagene Gene Therapy Introduction
13.8.4 Advantagene Revenue in Gene Therapy Business (2015-2020)
13.8.5 Advantagene Recent Development

14Analyst's Viewpoints/Conclusions

15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
About QYResearch
QYResearch is a leading global market research and consulting company. Established in 2007 in Beijing, China, QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and custom research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services.